Pharmaceuticals by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceuticals ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- NOK 49.36T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | NOK 94B | NOK 621.71 | 2.14% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | NOK 78.8B | NOK 1,136.74 | 0.43% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | NOK 47.3B | NOK 840.11 | 0.49% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | NOK 79.3B | NOK 1,214.49 | 0.36% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | NOK 82.9B | NOK 2,964.21 | 0.10% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | NOK 69.5B | NOK 498.82 | 0.50% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | NOK 44.1B | NOK 264.51 | 1.08% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | NOK 58B | NOK 2,901.22 | 1.73% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | NOK 87.7B | NOK 923.83 | 1.46% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | NOK 76.1B | NOK 452.57 | 2.59% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | NOK 43.5B | NOK 397.39 | 2.62% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | NOK 147.2B | NOK 755.52 | 1.35% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | NOK 45.2B | NOK 128.71 | 4.54% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | NOK 48.3B | NOK 277.61 | 2.69% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | NOK 58B | NOK 888.98 | 0.40% down | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | NOK 46.9B | NOK 488.54 | 1.51% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | NOK 63.5B | NOK 936.30 | 0.15% up | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | NOK 49.1B | NOK 587.74 | 0.31% up | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | NOK 93.6B | NOK 4,029.66 | 1.62% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | NOK 151.4B | NOK 2,359.05 | 0.97% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | NOK 73.2B | NOK 669.08 | 1.63% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | NOK 59.8B | NOK 422.72 | 1.30% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | NOK 50.7B | NOK 1,202.41 | 1.40% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | NOK 113.2B | NOK 584.34 | 2.89% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | NOK 38B | NOK 277.56 | 2.67% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | NOK 128B | NOK 256.06 | 2.05% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | NOK 255.3B | NOK 1,163.92 | 1.60% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | NOK 273.9B | NOK 377.98 | 0.59% up | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | NOK 68B | NOK 1,292.34 | 2.07% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | NOK 30.6B | NOK 157.54 | 0.74% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | NOK 73.3B | NOK 932.61 | 1.02% up | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | NOK 84.7B | NOK 105.96 | 2.30% up | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | NOK 71.2B | NOK 813.30 | 2.06% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | NOK 172.2B | NOK 2,625.26 | 0.27% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | NOK 237.2B | NOK 5,569.48 | 1.77% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | NOK 331B | NOK 814.58 | 0.53% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | NOK 199.5B | NOK 1,489.39 | 1.96% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | NOK 62.5B | NOK 1,538.21 | 0.48% up | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | NOK 73.2B | NOK 209.95 | 2.41% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | NOK 231B | NOK 201.46 | 1.49% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | NOK 121.4B | NOK 145.60 | 1.42% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | NOK 480.7B | NOK 411.97 | 0.42% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | NOK 1.56T | NOK 273.58 | 1.00% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | NOK 1.19T | NOK 582.16 | 2.24% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | NOK 381.8B | NOK 664.03 | 0.39% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | NOK 960.3B | NOK 9,282.61 | 0.15% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | NOK 1.32T | NOK 5,193.93 | 0.17% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | NOK 307.9B | NOK 499.31 | 1.00% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | NOK 447.8B | NOK 3,920.46 | 2.27% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | NOK 1.75T | NOK 1,010.12 | 0.62% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | NOK 3.34T | NOK 1,353.59 | 2.73% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | NOK 4.95T | NOK 2,801.24 | 1.44% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | NOK 56.4B | NOK 82.85 | 1.10% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | NOK 1.7T | NOK 386.18 | 2.25% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | NOK 12T | NOK 13,467.15 | 1.99% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | NOK 950.7B | NOK 474.27 | 0.77% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | NOK 6.43T | NOK 2,672.20 | 1.22% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | NOK 1.1T | NOK 459.32 | 0.44% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | NOK 2.87T | NOK 1,517.92 | 1.73% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | NOK 2.69T | NOK 1,737.00 | 1.82% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | NOK 662.7B | NOK 207.43 | 1.25% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7066 NOK).
Questions and answers
Which pharmaceuticals rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceuticals ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceuticals are in this ranking?
61 are ranked by short interest.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by short interest have a combined market value of NOK 49.36T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.